Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02067819 · ClinicalTrials.gov registry record · NA

Proof of Concept Study of an Oral Orthotic to Reduce Tic Severity in Chronic Tic Disorder and Tourette Syndrome

A NA study of Tourette Syndrome and Chronic Tic Disorder, sponsored by Weill Medical College of Cornell University.

Completed
Registry status
NA
Development phase
21
Enrollment target
1
Study location

NCT02067819 is a NA study of Tourette Syndrome and Chronic Tic Disorder that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 21 participants, below the 86-participant average among 33 other Tourette Syndrome trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02067819, a NA study of Tourette Syndrome and Chronic Tic Disorder, has completed, sponsored by Weill Medical College of Cornell University.

COMPLETED
Registry status
NA
Development phase
21 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to assess the feasibility of a trial on an oral orthotic for reducing tic severity in children ages 7-25 years with Tourette syndrome (TS) or Chronic Tic Disorder (CTD).

Interventions

  • DEVICE Active Oral Orthotic Treatment
  • DEVICE Placebo Oral Orthotic Treatment

Study Locations (1)

New York

  • Weill Cornell Medical College - New York

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2014-03
Est. Completion 2021-05
Phase NA

What the Registry Record Tells You About NCT02067819

The ClinicalTrials.gov registry entry for NCT02067819 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 86-participant average among 33 other Tourette Syndrome trials with a reported enrollment target (76% lower). The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Tourette Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Active Oral Orthotic Treatment is the first listed.

NCT02067819 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT02067819 about?

NCT02067819 is a clinical study titled "Proof of Concept Study of an Oral Orthotic to Reduce Tic Severity in Chronic Tic Disorder and Tourette Syndrome". The purpose of this study is to assess the feasibility of a trial on an oral orthotic for reducing tic severity in children ages 7-25 years with Tourette syndrome (TS) or Chronic Tic Disorder (CTD).

What is the current status of trial NCT02067819?

This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2014-03. Estimated completion is 2021-05.

What conditions does trial NCT02067819 study?

This clinical trial studies the following conditions: Tourette Syndrome, Chronic Tic Disorder.

What interventions are being tested in trial NCT02067819?

The interventions under investigation include: Active Oral Orthotic Treatment (DEVICE), Placebo Oral Orthotic Treatment (DEVICE).

Who is sponsoring clinical trial NCT02067819?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02067819 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tourette Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.